ImmunityBio

Nachrichten

ImmunityBio Aktie

Aktie

ISIN: US45256X1037 WKN: A2QQ2E SYM: 26CA Land Flagge US

USA

Zur Watchlist hinzufügen Zum Portfolio hinzufügen

Zum Portfolio hinzufügen

6,8700

EUR

-1,58 %

-0,1100 EUR

Letzter Kurs 15.05.26 Tradegate

ImmunityBio Aktie kaufen

Geldkurs

15.05.26

6,8100

EUR

300 STK

Briefkurs

15.05.26

6,9100

EUR

300 STK

Verkauf

Kauf

Hinweis
Verlängerte Handelszeiten
Mo-Fr von 07:30 bis 23:00 Uhr
Neu: Samstag von 14:00 bis 19:00 Uhr

Nachrichten zu ImmunityBio

Neueste Meldungen

IBRX UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026 Englische Nachricht

ROSEN, A LEADING LAW FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX Englische Nachricht

Artikel in Nachrichten zu ImmunityBio

Neueste
Meistgelesene

Bronstein, Gewirtz & Grossman LLC Urges ImmunityBio, Inc. Investors to Act: Class Action Filed Alleging Investor Harm 14.05.26 · newsfile
SHAREHOLDER ALERT: Berger Montague Reminds ImmunityBio, Inc. (IBRX) Investors of Class Action Lawsuit Deadline 14.05.26 · newsfile
IBRX SHAREHOLDER UPDATE: ImmunityBio (IBRX) Sued After FDA Flags Misleading Cancer Claims, Shares Plunge 21%, $2B Market Cap Lost -- Hagens Berman 14.05.26 · newsfile
IBRX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026 13.05.26 · newsfile
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX 12.05.26 · newsfile
Bronstein, Gewirtz & Grossman LLC Urges ImmunityBio, Inc. Investors to Act: Class Action Filed Alleging Investor Harm 12.05.26 · newsfile
IBRX SHAREHOLDER RIGHTS ALERT: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026 11.05.26 · newsfile
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX 11.05.26 · newsfile
IBRX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026 09.05.26 · newsfile
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX 08.05.26 · newsfile
IBRX CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026 07.05.26 · newsfile
IBRX SHAREHOLDER UPDATE: ImmunityBio (IBRX) Sued After FDA Flags Misleading Cancer Claims, Shares Plunge 21%, $2B Market Cap Lost -- Hagens Berman 07.05.26 · newsfile
IMMUNITYBIO, INC. SECURITIES FRAUD NOTICE: Berger Montague Informs ImmunityBio, Inc. (IBRX) Investors of a Securities Fraud Lawsuit 07.05.26 · newsfile
ImmunityBio Reports Record Q1 2026 Results: Net Product Revenue Increased Nearly 2.7x Year-Over-Year to $44 Million in Q1 2026 Expanding on the 2025 Full Year 700% Year-Over-Year Revenue Growth; Cash and Marketable Securities Total $381 Million 07.05.26 · Business Wire (engl.)
Bronstein, Gewirtz & Grossman LLC Urges ImmunityBio, Inc. Investors to Act: Class Action Filed Alleging Investor Harm 06.05.26 · newsfile
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX 06.05.26 · newsfile
SHAREHOLDER ALERT Securities Class Action Filed Against ImmunityBio, Inc. (IBRX) 06.05.26 · newsfile
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX 05.05.26 · newsfile
ImmunityBio to Present New Comparative Data, Scientific Advances in Non-Muscle Invasive Bladder Cancer CIS and an Update on BCG Naïve Registrational Trial at American Urological Association Annual Meeting 05.05.26 · Business Wire (engl.)
IBRX INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026 04.05.26 · newsfile
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX 03.05.26 · newsfile
IBRX CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026 02.05.26 · newsfile
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX 01.05.26 · newsfile
Bronstein, Gewirtz & Grossman LLC Urges ImmunityBio, Inc. Investors to Act: Class Action Filed Alleging Investor Harm 01.05.26 · newsfile
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX 30.04.26 · newsfile

1
2

24h
7 Tage
30 Tage
6 Monate

IBRX UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026 15.05.26 · newsfile · 124 Leser

IBRX SHAREHOLDER RIGHTS ALERT: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026 11.05.26 · newsfile · 184 Leser
IBRX SHAREHOLDER UPDATE: ImmunityBio (IBRX) Sued After FDA Flags Misleading Cancer Claims, Shares Plunge 21%, $2B Market Cap Lost -- Hagens Berman 14.05.26 · newsfile · 164 Leser
SHAREHOLDER ALERT: Berger Montague Reminds ImmunityBio, Inc. (IBRX) Investors of Class Action Lawsuit Deadline 14.05.26 · newsfile · 144 Leser
IBRX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026 09.05.26 · newsfile · 140 Leser
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX 11.05.26 · newsfile · 132 Leser
IBRX UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026 15.05.26 · newsfile · 124 Leser
IBRX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026 13.05.26 · newsfile · 120 Leser
ROSEN, A LEADING LAW FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX 14.05.26 · newsfile · 112 Leser
Bronstein, Gewirtz & Grossman LLC Urges ImmunityBio, Inc. Investors to Act: Class Action Filed Alleging Investor Harm 12.05.26 · newsfile · 104 Leser
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX 12.05.26 · newsfile · 104 Leser

IMMUNITYBIO, INC. SECURITIES FRAUD NOTICE: Berger Montague Informs ImmunityBio, Inc. (IBRX) Investors of a Securities Fraud Lawsuit 07.05.26 · newsfile · 476 Leser
INVESTOR DEADLINE: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit 20.04.26 · newsfile · 376 Leser
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX 27.04.26 · newsfile · 328 Leser
IBRX CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026 02.05.26 · newsfile · 272 Leser
IBRX INVESTOR ALERT: Berger Montague Advises ImmunityBio, Inc. (IBRX) Investors of a May 26, 2026 Deadline 22.04.26 · newsfile · 240 Leser
IBRX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026 28.04.26 · newsfile · 240 Leser
SHAREHOLDER ALERT Securities Class Action Filed Against ImmunityBio, Inc. (IBRX) 29.04.26 · newsfile · 236 Leser
ROSEN, NATIONAL TRIAL LAWYERS, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX 23.04.26 · newsfile · 208 Leser
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX 19.04.26 · newsfile · 192 Leser
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX 01.05.26 · newsfile · 188 Leser

Der nächste Crowd-Trade?: Vom Nischen-Biotech zum Retail-Hype: Diese Aktie dreht brutal auf 20.01.26 · wallstreetONLINE Redaktion · 9372 Leser
Almonty Industries, Vulcan Energy Resources & Co. – Tops & Flops der Community am Morgen 25.03.26 · Markt Bote · 9140 Leser
DAX, Pentixapharm Holding & Co. – Tops & Flops der Community am Nachmittag 19.02.26 · Markt Bote · 6336 Leser
Silber, Circus & Co. – Tops & Flops der Community am Morgen 20.01.26 · Markt Bote · 4064 Leser
Gerresheimer, Microbot Medical & Co. – Tops & Flops der Community am Morgen 28.11.25 · Markt Bote · 3248 Leser
Silber, ImmunityBio & Co. – Tops & Flops der Community am Morgen 19.01.26 · Markt Bote · 3024 Leser
Die größten Aufsteiger der Woche vom 21.01.-28.01.2026 in der wO Community 28.01.26 · wO Chartvergleich · 1852 Leser
Silber, Kloeckner & Co. – Tops & Flops der Community am Morgen 16.01.26 · Markt Bote · 1448 Leser
Die größten Aufsteiger der Woche vom 25.02.-04.03.2026 in der wO Community 04.03.26 · wO Chartvergleich · 1328 Leser
Almonty Industries, Nippon Densan & Co. – Tops & Flops der Community am Morgen 04.03.26 · Markt Bote · 1172 Leser

ImmunityBio News

ImmunityBio News: Auf dieser Seite finden Sie alle ImmunityBio News und Nachrichten zur ImmunityBio Aktie. Dies beinhaltet die Agenturmeldungen auf wallstreet-online.de, aber auch ImmunityBio News von einer Vielzahl an Gastautoren, Partnern und Analysten.